- Accesswire•yesterdayIMPORTANT SPECTRUM PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of shareholders of Spectrum Pharmaceuticals, Inc.
Lead Plaintiff Deadline is November 21, 2016 NEW YORK, NY / ACCESSWIRE / September 28, 2016 / Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Spectrum ...
- GlobeNewswire•2 days agoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016
NEW YORK, Sept. 28, 2016-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals Inc. and certain of its ...
- Insider Monkey•2 days ago
On September 14, 2016, the FDA’s Oncologic Drugs Advisory Committee met to evaluate and discuss a drug called apaziquone. Apaziquone is a development stage bladder cancer treatment, which small cap biotech Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is investigating as a therapy designed to reduce the risk of recurrence of bladder cancer in patients that have juts […]
Spectrum Pharmaceuticals, Inc. (SPPI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Ask||5.20 x 5000|
|Day's Range||4.57 - 4.74|
|52wk Range||4.14 - 7.74|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-5.34|
|Avg Vol (3m)||875,018|
|Dividend & Yield||0.00 (0.00%)|